Vaxcyte, Inc. · NASDAQ:PCVX
Dhaliwal Harpreet S. sold 17,000 Vaxcyte, Inc. shares (Form 4)
Traded Nov 11, 2026 · Filed Nov 13, 2026
On Nov 11, 2026, Dhaliwal Harpreet S. (Chief Technical Ops Officer) sold 17,000 Vaxcyte, Inc. shares at an average US$67.83 for US$1.15M under a trading plan, leaving 68,085 shares. Filed Nov 13, 2026 (Form 4).
- Sold
- 17,000 shares
- Price
- US$67.83 average (US$67.33 to US$68.82)
- Value
- US$1.15M
- Holding after
- 68,085 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Technical Ops Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Common Stock | Option exercise | 17,000 | US$24.79 | 85,085 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 7,135 | US$67.33 | 77,950 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 9,345 | US$68.16 | 68,605 | Direct |
| Nov 11, 2026 | Common Stock | Sale | 520 | US$68.82 | 68,085 | Direct |
Source
Download original · View original at SEC
Related
- Vaxcyte, Inc.
- Dhaliwal Harpreet S.
- Vaxcyte, Inc. shareholders
- Form 4 · Dhaliwal Harpreet S. · Sep 9, 2026
- Form 4 · Dhaliwal Harpreet S. · Sep 2, 2026
- Form 4 · Dhaliwal Harpreet S. · Aug 5, 2026
- Schedule 13G · Wellington Management Group LLP · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Form 4 · Cowan Elvia · Nov 4, 2026
- Form 4 · Wassil Jim · Nov 4, 2026